Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
ALX Oncology Holdings ( (ALXO) ) has shared an update.
Sophia Randolph, the Chief Medical Officer of ALX Oncology Holdings Inc., has announced her resignation to seek new professional avenues, effective October 11, 2024. Her departure is amicable, with no disputes over company operations. ALX Oncology is set to look for her replacement and has agreed to a generous separation package for Dr. Randolph, including a lump sum payment, extended health benefits, full vesting of certain stock options, and a consulting agreement to aid in the transition. This move is a forward-looking statement and carries the usual risks associated with such changes in management.
For an in-depth examination of ALXO stock, go to TipRanks’ Stock Analysis page.